Clik here to view.
FDA Acknowledges Receipt of 22nd Century’s Very Low Nicotine Modified Risk...
Thursday, March 31st 2016 at 2:37pm UTC Company intends to offer American smokers the first and only reduced exposure product choice CLARENCE, N.Y.–(BUSINESS WIRE)– 22nd Century Group, Inc. (NYSE MKT:...
View ArticleClik here to view.
Tokai Pharmaceuticals to Present at the 15th Annual Needham Healthcare...
Wednesday, April 6th 2016 at 11:00am UTC BOSTON–(BUSINESS WIRE)– Tokai Pharmaceuticals Inc. (NASDAQ:TKAI), a biopharmaceutical company focused on developing and commercializing innovative therapies...
View ArticleClik here to view.
St. Jude Medical Announces First Quarter 2016 Earnings Conference Call
Tuesday, April 5th 2016 at 8:15pm UTC ST. PAUL, Minn.–(BUSINESS WIRE)– St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced that it will report financial results for its...
View ArticleClik here to view.
Pfizer Receives European Approval for New Multi-Dose Vial Presentation of...
Wednesday, April 6th 2016 at 3:00pm UTC Four-Dose Vial Will Help Address Infrastructure Challenges in Developing Countries NEW YORK–(BUSINESS WIRE)– Pfizer Inc. (NYSE:PFE) announced today that the...
View ArticleClik here to view.
Pfizer Taps IBM for Research Collaboration to Transform Parkinson’s Disease Care
Thursday, April 7th 2016 at 12:30pm UTC Experimental “Internet of Things” System Uses Connected Devices to Enable Remote Measurement of Health and Quality of Life in Real-Time Multi-Year Project Could...
View ArticleClik here to view.
Catabasis Pharmaceuticals to Present at Needham and Company’s 15th Annual...
Thursday, April 7th 2016 at 12:00pm UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage biopharmaceutical company, today announced that Jill C. Milne,...
View ArticleClik here to view.
CSHL Reports That the U.S. Patent Office Denies All 4 Petitions Filed by...
Wednesday, April 6th 2016 at 8:37pm UTC COLD SPRING HARBOR, N.Y.–(BUSINESS WIRE)– Cold Spring Harbor Laboratory (CSHL) is pleased to report that the U.S. Patent & Trademark Office has denied all 4...
View ArticleClik here to view.
Omeros to Present at the 15th Annual Needham Healthcare Conference
Thursday, April 7th 2016 at 11:00am UTC SEATTLE–(BUSINESS WIRE)– Omeros Corporation (NASDAQ:OMER), a biopharmaceutical company committed to discovering, developing and commercializing both...
View ArticleClik here to view.
Alnylam to Webcast Presentation at 15th Annual Needham Healthcare Conference
Wednesday, April 6th 2016 at 8:00pm UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that management will...
View ArticleClik here to view.
WellSpring Pharma Services Completes $3 Million Capital Investment and Forms...
Thursday, April 7th 2016 at 12:00pm UTC OAKVILLE, Ontario–(BUSINESS WIRE)– WellSpring Pharma Services, leading specialists in formulation, development and manufacturing for a wide range of solid,...
View ArticleClik here to view.
Phase 2b Data on Inhaled Levodopa CVT-301 Featured in Invited Science Session...
Thursday, April 7th 2016 at 11:00am UTC Acorda to present additional posters on CVT-301 at AAN ARDSLEY, N.Y.–(BUSINESS WIRE)– Acorda Therapeutics, Inc. (Nasdaq:ACOR) today announced that data from a...
View ArticleClik here to view.
Tyme Technologies, Inc. Reports Year-End Financial Results for 2015
Monday, April 11th 2016 at 12:30pm UTC NEW YORK–(BUSINESS WIRE)– Tyme Technologies, Inc. (OTC QB: TYMI), a clinical-stage pharmaceutical company focused on discovering and developing highly-targeted...
View ArticleClik here to view.
Acorda Therapeutics Announces Preliminary Tender Offer Results and Acceptance...
Monday, April 11th 2016 at 12:59pm UTC NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO CANADA, JAPAN, AUSTRALIA, SOUTH AFRICA, HONG KONG OR IN ANY OTHER JURISDICTION...
View ArticleClik here to view.
RenovaCare, Inc. Completes Engineering, Research, and Studies Required to...
Tuesday, April 12th 2016 at 1:15pm UTC NEW YORK & PITTSBURGH–(BUSINESS WIRE)– RenovaCare, Inc., a developer of novel medical grade liquid spray devices and patented CellMist™ and SkinGun™...
View ArticleClik here to view.
Remedy Pharmaceuticals Announces Two Oral Presentations on Results of...
Tuesday, April 12th 2016 at 1:30pm UTC NEW YORK–(BUSINESS WIRE)– Remedy Pharmaceuticals, a privately-held, phase 3-ready pharmaceutical company focused on bringing life saving hospital-based treatment...
View ArticleClik here to view.
B-School Innovation Professor Discovers Pathway between Diabetes and...
Tuesday, April 12th 2016 at 2:00pm UTC –Hyperinsulinemia leads to more than 40% of all Alzheimer’s disease cases– *Follow @NYUStern on Twitter for the latest in faculty research* NEW YORK–(BUSINESS...
View ArticleClik here to view.
SIGA Emerges from Chapter 11 Bankruptcy Protection
Tuesday, April 12th 2016 at 8:44pm UTC NEW YORK–(BUSINESS WIRE)– SIGA Technologies, Inc. (SIGA) (OTCMKTS:SIGAQ), a company specializing in the commercialization of solutions for serious unmet medical...
View ArticleClik here to view.
Ovid Therapeutics Expands Leadership Team and Scientific Advisory Board
Wednesday, April 13th 2016 at 12:00pm UTC Amit Rakhit, M.D., M.B.A., Appointed Chief Medical & Portfolio Management Officer Daniel H. Geschwind, M.D., Ph.D., Joins Ovid’s Scientific Advisory Board...
View ArticleClik here to view.
Acorda to Host Conference Call to Discuss First Quarter 2016 on April 28, 2016
Thursday, April 14th 2016 at 11:00am UTC ARDSLEY, N.Y.–(BUSINESS WIRE)– Acorda Therapeutics, Inc. (Nasdaq:ACOR) will host a conference call and webcast to report its first quarter 2016 financial...
View ArticleClik here to view.
22nd Century to Emphasize Disruptive and Proprietary Smoking Harm Reduction...
Thursday, April 14th 2016 at 2:22pm UTC Company Releases 2015 Annual Report Letter to Shareholders CLARENCE, N.Y.–(BUSINESS WIRE)– 22nd Century Group, Inc. (NYSE MKT: XXII), a plant biotechnology...
View Article